View by Specialty

Trending

HIV virus particles NIAID
March 10, 2025
3 min read
Save

Two more people potentially cured of HIV

Bone/Mineral Metabolism News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 09, 2019
1 min read
Save

Osteoporosis prevalent in patients with COPD

More than one-third of patients with COPD worldwide may have osteoporosis, according to a systematic review and meta-analysis published in CHEST.

SPONSORED CONTENT
August 07, 2019
3 min read
Save

Parathyroid hormone replacement safe, effective in chronic hypoparathyroidism

Parathyroid hormone replacement safe, effective in chronic hypoparathyroidism

Adults with chronic hypoparathyroidism treated with recombinant human parathyroid hormone 1-84 for 5 years experienced sustained improvements in mineral homeostasis and modest increases in bone turnover markers, whereas serum calcium remained in the target range with reductions in oral calcium supplements, according to findings from a small, open-label extension study.

Trending

HIV virus particles NIAID
March 10, 2025
3 min read
Save

Two more people potentially cured of HIV

SPONSORED CONTENT
August 07, 2019
2 min read
Save

Black race confers lower fracture risk in diabetes

Black race confers lower fracture risk in diabetes

Black adults with type 1 or type 2 diabetes do not experience additional major osteoporotic fracture risk conferred by diabetes, according to a database analysis published in The Journal of Clinical Endocrinology & Metabolism

SPONSORED CONTENT
July 31, 2019
3 min read
Save

Tight glycemic targets, insulin use increase fracture risk among older men with type 2 diabetes

Tight glycemic targets, insulin use increase fracture risk among older men with type 2 diabetes

Older men with type 2 diabetes and low baseline HbA1c were more likely to sustain any fracture or a hip fracture over 3 years than similar men with HbA1c between 7.5% and 8.5%, with insulin use further increasing fracture risk, according to findings published in the Journal of Bone and Mineral Research.

SPONSORED CONTENT
July 29, 2019
3 min read
Save

Exercise prevents bone loss after bariatric surgery

Exercise prevents bone loss after bariatric surgery

Women with severe obesity who underwent Roux-en-Y gastric bypass surgery followed by a 6-month exercise program did not experience the bone loss observed in similar women who underwent gastric bypass followed by standard care, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

SPONSORED CONTENT
July 26, 2019
2 min read
Save

Risk for poor bone health persists 10 years after gastric bypass

Risk for poor bone health persists 10 years after gastric bypass

A cohort of adults with obesity who underwent Roux-en-Y gastric bypass showed markers for poor bone health in the decade after surgery, including elevated bone turnover markers and lower areal bone mineral density, according to findings published in Bone.

SPONSORED CONTENT
July 22, 2019
1 min read
Save

Genetic origins of anorexia both psychiatric, metabolic

Genetic origins of anorexia both psychiatric, metabolic

Results from a genome-wide association study published in Nature Genetics implicated metabo-psychiatric origins of anorexia nervosa, supporting the reconceptualization of the disorder as both metabolic and psychiatric.

SPONSORED CONTENT
July 19, 2019
2 min read
Save

Recent in-depth features from Endocrine Today

Each month in its cover story, Endocrine Today offers comprehensive reporting on issues of interest to practicing endocrinologists, diabetes educators and other clinicians.

SPONSORED CONTENT
July 19, 2019
2 min read
Save

1 in 4 early-middle-aged adults has osteopenia

1 in 4 early-middle-aged adults has osteopenia

More than 25% of early-middle-aged adults had osteopenia in their neck, according to findings recently published in the Journal of the American Osteopathic Association.

SPONSORED CONTENT
July 11, 2019
2 min read
Save

Greater hip BMD gains seen with denosumab vs. teriparatide after long-term bisphosphonate use

Greater hip BMD gains seen with denosumab vs. teriparatide after long-term bisphosphonate use

Long-term bisphosphonate users who switched to the human monoclonal antibody denosumab experienced a gain in hip bone mineral density in the first year of therapy, whereas patients who switched to teriparatide experienced a transient loss in hip BMD, suggesting clinicians should exercise caution when changing osteoporosis agents for patients at high risk for hip fracture, according to a real-world analysis of electronic medical records.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails